Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Arthritis and AMPD1[original query] |
---|
Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. Arthritis and rheumatism 2006 Sep 54 (9): 2830-9. Wessels Judith A M, Kooloos Wouter M, De Jonge Robert, De Vries-Bouwstra Jeska K, Allaart Cornelia F, Linssen Annelies, Collee Gerard, De Sonnaville Peter, Lindemans Jan, Huizinga Tom W J, Guchelaar Henk-J |
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis and rheumatism 2007 Jun 56 (6): 1765-75. Wessels Judith A M, van der Kooij Sjoerd M, le Cessie Saskia, Kievit Wietske, Barerra Pilar, Allaart Cornelia F, Huizinga Tom W J, Guchelaar Henk-Jan, |
Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians. Pharmacogenetics and genomics 2009 Oct 19 (10): 823-8. Sharma Shruti, Das Mitashree, Kumar Ashok, Marwaha Vishal, Shankar Subramanian, Singh Paramjeet, Raghu Padmanabhan, Aneja Ritu, Grover Rahul, Arya Vivek, Dhir Varun, Gupta Rajiva, Kumar Uma, Juyal Ramesh C, K Thelma |
Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate. Pharmacogenetics and genomics 2010 Jun 20 (6): 367-76. Stamp Lisa K, Chapman Peter T, O'Donnell John L, Zhang Mei, James Jill, Frampton Christopher, Barclay Murray L, Kennedy Martin A, Roberts Rebecca |
Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure. Pharmacogenomics 2012 Jul 13 (9): 9. Fransen J, Kooloos WM, Wessels JA, Huizinga TW, Guchelaar HJ, van Riel PL, Barrera P |
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. The pharmacogenomics journal 2012 Mar . Owen SA, Hider SL, Martin P, Bruce IN, Barton A, Thomson W |
Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis. Pharmacogenomics 2017 Jan 18 (2): 175-195. Chen Yuehong, Zou Kun, Sun Jianhong, Yang Yuan, Liu Ga |
Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis. The Journal of rheumatology 2017 Jun . Zajc Avramovi? Mojca, Dolžan Vita, Toplak Nataša, Accetto Meta, Lusa Lara, Av?in Tad |
Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models. Frontiers in pharmacology 2018 2 9 20. Jenko Barbara, Tomši? Matija, Jeki? Biljana, Mili? Vera, Dolžan Vita, Praprotnik Son |
Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients. International journal of rheumatic diseases 2021 Mar . Singh Ankita, Gangadharan Harikrishnan, Gupta Vikas, Patro Pradeepta S, Misra Ramnath, Aggarwal Ami |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: